CVS Health: Q3 EPS more than halved
(CercleFinance.com) - CVS Health has reported Q3 2024 adjusted EPS that was less than half its level a year ago (-51%) at $1.
09, penalized (about 63 cents) by charges for premium deficiency reserves in its healthcare benefits segment.
The group explains that these exceptional charges, totaling $1.1bn, relate to anticipated losses for the last three months of the year, within its Medicare and individual exchange product lines.
CVS Health's adjusted operating profit fell 42.8% to $2.55bn, on revenues that rose 6.3% to over $95.4bn, driven by the healthcare benefits and consumer pharmacy-wellness segments.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
09, penalized (about 63 cents) by charges for premium deficiency reserves in its healthcare benefits segment.
The group explains that these exceptional charges, totaling $1.1bn, relate to anticipated losses for the last three months of the year, within its Medicare and individual exchange product lines.
CVS Health's adjusted operating profit fell 42.8% to $2.55bn, on revenues that rose 6.3% to over $95.4bn, driven by the healthcare benefits and consumer pharmacy-wellness segments.
Copyright (c) 2024 CercleFinance.com. All rights reserved.